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Tissue Engineering and Regenerative Medicine
Overexpression of Polysialylated Neural Cell
Adhesion Molecule Improves the Migration Capacity
of Induced Pluripotent Stem Cell-Derived
Oligodendrocyte Precursors
MARCIN CZEPIEL, LASSE LEICHER, KATJA BECKER, ERIK BODDEKE, SJEF COPRAY
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ABSTRACT
Cell replacement therapy aiming at the compensation of lost oligodendrocytes and restoration of
myelination in acquired or congenital demyelination disorders has gained considerable interest since
thediscoveryof inducedpluripotent stemcells (iPSCs). Patient-derived iPSCsprovidean inexhaustible
source for transplantable autologous oligodendrocyte precursors (OPCs). The first transplantation
studies in animal models for demyelination with iPSC-derived OPCs demonstrated their survival
and remyelinating capacity, but also revealed their limited migration capacity. In the present study,
we induced overexpression of the polysialylating enzyme sialyltransferase X (STX) in iPSC-derived
OPCs to stimulate the production of polysialic acid-neuronal cell adhesion molecules (PSA-NCAMs),
known to promote and facilitate the migration of OPCs. The STX-overexpressing iPSC-derived OPCs
showed a normal differentiation and maturation pattern and were able to downregulate PSA-
NCAMs when they became myelin-forming oligodendrocytes. After implantation in the demyelinated
corpus callosum of cuprizone-fed mice, STX-expressing iPSC-derived OPCs demonstrated a significant
increase in migration along the axons. Our findings suggest that the reach and efficacy of iPSC-
derived OPC transplantation can be improved by stimulating the OPC migration potential via specific
gene modulation. STEM CELLS TRANSLATIONAL MEDICINE 2014;3:1100–1109
INTRODUCTION
Transplantation of young myelin-forming cells
has been considered a therapeutic option to com-
pensate for lost or nonfunctional oligodendro-
cytes and to restore myelin sheets in congenital
(e.g., vanishing whitematter disease) or acquired
(e.g., multiple sclerosis [MS]) demyelinating dis-
orders, because no effective pharmacological
approach to induce remyelination is available.
Many studies in experimental animals have dem-
onstrated the feasibility of such a cell graft
approach. However, the lack of a suitable, clini-
cally acceptable source for transplantable autolo-
gous oligodendrocyte precursor cells (OPCs) has
obviated any aspiration for a clinical application,
so far. The ground-breaking discovery of induced
pluripotent stem cells (iPSCs) [1] has provided an
unprecedented tool to generate large numbers of
autologousOPCs froma fewsomatic cells (e.g., iso-
lated from a small skin biopsy). Reprogramming
patient-derived somatic cells to pluripotency and
subsequent differentiation into an oligodendro-
cytic cell lineage has revitalized the idea to test cell
transplantation as a clinical approach for treating
demyelinating disorders.
Recently, Wang et al. [2] demonstrated the
ability of iPSC-derived OPCs to myelinate and
rescue amousemodel of congenital hypomyelina-
tion. Our laboratory has transplanted iPSC-derived
OPCs into a mouse model, mimicking local demy-
elination such as occurs in MS. We could dem-
onstrate that iPSC-derived OPCs survived and
remyelinated the corpus callosum around the
injection site [3]. We noticed that the stereo-
tactically injected iPSC-derived OPCs, remarkably,
had only a limited potential to migrate along the
axon bundles of the corpus callosum. For cell re-
placement therapy, it is crucial that iPSC-derived
OPCs be able migrate freely all the way to lesion
sites after transplantation [4].Thus, itwouldbede-
sirable to manipulate the transplanted OPCs such
that they have an increased migration potential
that does not interfere with their survival.
The process of migration and adhesion in
OPCs is mainly mediated by adhesion molecules,
with amajor role for the neural cell adhesionmol-
ecule (NCAM) [5, 6]. NCAM is amember of the im-
munoglobulin family and has the ability to bind
long homopolymers of sialic acid. These polysialic
acid (PSA) residues are attached to the core gly-
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migration owing to reduced homophilic NCAM-NCAM interac-
tions and cell-cell adhesions [9]. The PSA residues are attached
to NCAM via two different enzymes: polysialyltransferase (PST)
or sialyltransferase X (STX) [7, 10]. PSA-NCAM is expressed on
demyelinated axons, activated astrocytes, Schwann cells, and
OPCs, and it has been associated with OPC and Schwann cell mi-
gration [11]. In addition, a strong correlation has been demon-
strated between the disappearance of PSA-NCAM on both
axons and OPCs and the initiation of the myelinating process
[9, 12]. PSA-NCAM is of high importance for themigration ofOPCs
but forms an inhibiting factor in myelination and needs to be
downregulated on initiation of myelination [9, 13].
Overexpression of PSA-NCAMon iPSC-derivedOPCs via trans-
duction of these cells with PST or STX could be a useful tool to
accomplish better migration after transplantation. The con-
cept has been tested with STX-transduced Schwann cells im-
planted after spinal cord injury or implanted in the brain after
lysophosphatidyl-choline lesioning [14, 15]. Indeed, the grafted
STX-overexpressing Schwann cells demonstrated significantly in-
creased migration and, importantly, silenced STX expression on
the start of myelin-basic protein (MBP) expression and the initi-
ation of remyelination of axons.
In the present study, we aim to induce overexpression of STX
in iPSC-derivedOPCs via lentiviral transduction and compare their
migratory capacity with control iPSC-derived OPCs in vitro and in
vivo.Moreover, wewant to establish the downregulation of PSA-
NCAMs in the iPSC-derivedOPCs onmaturation into oligodendro-
cytes (i.e., on the start of MBP expression).
MATERIALS AND METHODS
Generation of iPSCs
For the generation of iPS cells, E14 mouse embryonic fibroblasts
(MEFs) were isolated from C57BL/6 mice. These fibroblasts were
reprogrammed using polycistronic lentivirus harboring Oct4,
Sox2, Klf4, and cMyc coding sequences [16]. In brief, MEFs were
cultured in Dulbecco’s modified Eagle’s medium (DMEM) until
passage 3. For lentiviral particle production, HEK293T cells were
transfected (Fugene-HD; Roche, Almere, TheNetherlands, http://
www.roche-applied-science.com) with a polycistronic lentiviral
plasmid, together with packaging and envelope plasmids
(Addgene, Cambridge,U.K., http://www.addgene.org). Lentivirus
containing supernatant was collected and mixed with 8 mg/ml
polybrene (Sigma-Aldrich, Zwijndrecht, The Netherlands, http://
www.sigmaaldrich.com), filtered through an 0.45-mmfilter (What-
man, The Netherlands, http://www.whatman.com) and directly
added toMEFs. Threedaysafter transduction, the cellswere trypsi-
nized and replated on irradiated mouse embryonic fibroblasts
(iMEFs) and cultured in embryonic stem cell (ES) medium. One
week after replating of infected MEFs, the first ES-like colonies
started to appear. The colonies were picked and propagated on
iMEFs in ES medium (knockout DMEM [KO-DMEM], 15% knock-
out serum replacement, 1% nonessential amino acids [all Invi-
trogen, Breda, The Netherlands, http://www.invitrogen.com];
2 mM L-glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin
[all PAA, Co¨lbe, Germany, http://www.paa.com]; 100 mM
2-mercaptoethanol, supplemented with 1,000 U/ml leukemia in-
hibitory factor [LIF; Millipore, Amsterdam, The Netherlands,
http://www.millipore.com]). Subsequent passages were done
using trypsin-based dissociation. To analyze the differentiation
potential of our iPS cells, they were cultured as embryoid bodies
(EBs) for 8 days and transferred onto gelatin-coated coverslips
for another 5 days. The cells were then fixed and stained for
markers of the three germ layers.
Reverse Transcriptase-Polymerase Chain Reaction
Reverse transcriptase-polymerase chain reaction (RT-PCR) analy-
sis of the expression of the major pluripotency transcription fac-
tors (Oct4, Klf4, Nanog, Sox2, and cMyc)was performed onmRNA
collected from pooled MEFs, the mouse iPSCs, iPSC-derived EBs,
and mouse ES cells. The forward and reverse primers used are
listed in Table 1. Each RT-PCR analysis was done in triplicate.
For analysis of STX overexpression, quantitative RT-PCR (qRT-
PCR) was applied using primers complementary to the human
STX coding sequence.
Oligodendrocyte Differentiation of iPSCs
The procedure to differentiate mouse iPSCs into an oligodendro-
cytic cell lineage has been previously described [3]. Mouse iPS
medium (KO-DMEM, 15% knockout serum replacement, 1%
nonessential amino acids [all Invitrogen], 100 U/ml penicillin,
100 mg/ml streptomycin, 1% L-glutamine [all PAA], 100 mM
b-mercaptoethanol), supplemented with 1,000 U/ml LIF (Milli-
pore), was used to keep the iPSCs in a pluripotent state.
Trypsin-based dissociation was applied to start the cultivation
of embryonic bodies on nonadherent dishes. These were coated
with 1% bovine serum albumin in phosphate-buffered saline
(PBS) to prevent early adhesion of the cells. Embryonic bodies
were propagated for 8 days in mouse EB medium (KO-DMEM,
15% fetal calf serum [FCS; PAA], 1% L-glutamine, 1% nonessential
amino acids, 100 U/ml penicillin, 100 mg/ml streptomycin, and
100mMb-mercaptoethanol). For differentiation toward a neural
stem cell (NSC) stage, the cells were plated on laminin-coated ad-
herent dishes and cultured in serum free N2 medium (DMEM/
F-12 [Invitrogen], 1% N2 supplement [PAA], 1% L-glutamine,
100 U/ml penicillin, 100 mg/ml streptomycin, 1% nonessential
amino acids, and 2 mg/ml heparin [Sigma-Aldrich]), supple-
mented with 20 ng/ml epidermal growth factor (EGF, Invitrogen)
and 20 ng/ml basic fibroblast growth factor (bFGF; Invitrogen) for
7–10 days. After dissociation of the cells with Accutase (Sigma-
Aldrich), the cells were transferred onto coverslips coated with
poly-L-ornithine hydrobromide (Sigma-Aldrich) and laminin
(Sigma-Aldrich). The cells were then differentiated to OPCs in se-
rum free N2 medium supplemented with 10 ng/ml platelet-
derived growth factor (PDGF, PeproTech, Rocky Hill, NJ, http://
www.peprotech.com) for 4 days and purified by expression
of the receptor PDGF receptor-a (PDGFRa) using FACsorting
(supplemental online Fig. 1). Continuing differentiation of the
iPSC-derived OPCs to mature oligodendrocytes was induced by
culturing in serum free N2 medium supplemented with 10 ng/
ml triiodothyronine (T3; Sigma-Aldrich) and 10 ng/ml neuro-
trophin 3 (NT3; R&D Systems Inc., Minneapolis, MN, http://
www.rndsystems.com) for an additional 7 days. Culturing took
place at 37°C, 5% CO2, and 95% humidity.
Coculture of iPS-Derived OPCs With Dorsal Root
Ganglion Neurons
In order to examine the myelinating capacity of IPS-derived
OPCs in vitro, we cocultured them with rat dorsal root ganglion
(DRG) neurons. DRGs were explanted from 15-day-old Wistar
Czepiel, Leicher, Becker et al. 1101
www.StemCellsTM.com ©AlphaMed Press 2014
rat embryos and dissociated in a solution containing papain (1.2
U/ml, Sigma-Aldrich), L-cysteine (0.24 mg/ml, Sigma-Aldrich), and
DNase I (40mg/ml, Roche) for 1 hour at 37°C. Thedissociated cells
wereplatedat adensity of 60,000 cells per 13-mmcoverslip (VWR
International, Radnor, PA, http://www.us.vwr.com) precoated
with poly-L-lysine (5 mg/ml, Sigma-Aldrich) and growth factor re-
duced Matrigel (1:40 dilution; BD Biosciences, San Diego, CA,
http://www.bdbiosciences.com). DRG neurons were cultured
for 21 days in DMEM (Gibco, Grand Island, NY, http://www.
invitrogen.com; supplemented with 10% FCS, Bodinco BV,
Alkmaar, The Netherlands, http:/www,bodinco.nl; L-glutamine
and penicillin/streptomycin, Invitrogen) in the presence of nerve
growth factor (100 ng/ml, Serotec Ltd., Oxford, U.K., http://www.
serotec.com). The cells were pulsed four times for 2 dayswith flu-
orodeoxyuridine (10 mM, Sigma-Aldrich) to remove contaminat-
ing proliferating cells, in particular fibroblasts and Schwann cells.
Thepurity of theDRGculturewasmicroscopically confirmed. Sub-
sequently, 50,000 iPS-derived OPCs were seeded onto coverslips
containing the DRG neurons with extensive axonal outgrowth.
The following day, the medium was changed to N2 with 30 ng/
ml T3 and 10 ng/mlNT3.OPCswere coculturedwith theDRGneu-
rons for 14 days with a medium change every second day. After
that period, the cells were fixed and subjected to immunocyto-
chemical staining for MBP and neurofilaments.
ThemyelinationefficiencyofSTX-transfected iPS-derivedOPCs
and control empty vector iPS-derived OPCs in the DRG cocultures
was quantified by analysis of immunofluorescence images, 15 per
coverslip, using ImageJ software. In brief, in merged images of the
red channel (neurofilament) and green channel (MBP), yellow
areas (indicatingmyelinated axons) weremeasured and divided
by the area covered only by green (representing the oligodendro-
cytes and their extensions); this quotient was used as an indica-
tion of the myelination efficiency. Myelination efficiency data
derived from the cocultures with control (empty vector) iPS-
derived OPCs were normalized to 1.
Transfection With STX Gene
To induce overexpression of PSA-NCAMs in iPSC-derived neural
stem cells (NSCs), a lentiviral vector was applied, introducing the
gene encoding for the human polysialyltransferase ST8SIA2 (STX).
HEK 293 (human embryonic kidney) cells were transduced with
the lentiviral vectors pLenti–GIII–CMV-hST8SIA2 (encoding for
STX and puromycin resistance) and pLenti–GIII–CMV Blank (encod-
ing for puromycin resistance) as a control (both from Applied Bio-
logical Materials Inc., Richmond, British Columbia, Canada, http://
www.abmgood.com), using Fugene HD (Promega, Madison, WI,
http://www.promega.com). Two hours before transfection, the
culture medium (standard medium: DMEM, 10% FCS, 100 U/ml
penicillin, and 100mg/ml streptomycin) of 80% confluent HEK cells
was refreshedtoensurehightransfectionefficiency.Theviral super-
natant of these cells was collected 48 hours after transfection and
passed through a 0.45-mm pore Acrodisc filter (Whatman) to
remove cell debris. Centrifugation (2,000g, 20 minutes) of the fil-
trate in an Amicon Ultra tube (Millipore) concentrated the virus
in 200ml of standardmedium. The lentiviral vectors were diluted
in N2 medium supplemented with EGF, bFGF and 8 mg/ml hex-
adimethrine bromide (Polybrene, Sigma-Aldrich). The medium
of the targeted NSCs was replaced with this virus-containing
N2medium for 24 hours. Successfully transduced NSCs were se-
lected by culturing the cells in N2 medium supplemented with
EGF, bFGF, and 1 mg/ml puromycin for 4 days. The cells were cul-
tured in N2medium supplemented with bFGF and EGF with ongo-
ing puromycin selection at 0.5 mg/ml.
Western Blot Analysis
iPS-derived OPCs from the control and STX-transfected cell lines
were analyzed for expression of NCAM and PSA-NCAM. OPCs
were lysed in RIPA+ (RIPA buffer plus protease inhibitors,
Sigma-Aldrich) lysis buffer, and samples were sonicated and
centrifuged for 10 minutes at 4°C at maximum speed. The super-
natant was collected and the protein concentration determined
using RC DC protein assay (Bio-Rad, Hercules, CA, http://www.
bio-rad.com). A protein amount of 60 mg was diluted in 63 sam-
ple buffer (0.625MTris, pH6.8, 20%SDS, 87%glycerol, 2-mercap-
toethanol, 0.1% bromophenol blue) boiled at 95°C for 5 minutes
and placed on ice before loading on a 7.5% acrylamide gel. The
proteins were separated at 110 V. For blotting, a nitrocellulose
membranewas applied according tomanufacturer’s instructions.
Blocking was mediated for 1 hour in 5% nonfat dry milk in PBS-
Tween (PBS-T). For detection of NCAMs, membranes were incu-
bated in rabbit anti-NCAM antibody (AB5032, Millipore) (1:3,000
dilution); for detection of PSA-NCAM, we used mouse anti-PSA-
NCAM (MAB5324, Millipore) (1:2,000 dilution), all in PBS-T with
5% nonfat dry milk. After incubation overnight at 4°C, the mem-
branes were incubated for 1 hour at room temperature in bio-
tinylated secondary antibodies (all from Vector Laboratories,
Burlingame, CA, http://www.vectorlabs.com). For PSA-NCAM,
we used goat anti-mouse IgM (BA-2020; dilution 1:100) and for
NCAM, goat anti-rabbit IgG (BA-1000, Vector Laboratories) The
membranes were then incubated with streptavidin-biotinylated
horseradish peroxidase complex (RPN1051; Amersham, GE
Healthcare, Little Chalfont, U.K., http://www.gehealthcare.
com), diluted 1:5,000 in PBS for 15 minutes at room temper-
ature. Proteins were detected using the ECL Prime system
Table 1. Primers used for reverse transcriptase-polymerase chain reaction








Abbreviation: GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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(RPN2232; Amersham, GE Healthcare) according to the man-
ufacturer’s protocol.
In Vitro Migration Assay
To quantify the migratory potential of the iPS-derived OPCs,
a standardized scratch-migration assaywas performed. Three dif-
ferent OPC suspensions (i.e., cells overexpressing STX gene, cells
transduced with an empty vector, and nontransduced cells) were
seeded, each in 4 uncoated wells of a 12-well tissue culture plate
and incubated in N2 medium complemented with PDGF (10 ng/
ml) at 37°C overnight. After incubation, a standard gap across the
seeded cell suspensions was created by a scratch with a 10-ml pi-
pette tip. Afterward, the medium was refreshed to remove the
debris (dead and floating cells). Photographs were taken at 0,
24, 48, and 72 hours after scratching to record and quantify the
spontaneous migratory activity of the OPCs to bridge the gap.
For quantification, the cells were pseudocolored in the imaging
software (ImageJ), and the percentage of the colored area in
the photographs was calculated. The average values for the dif-
ferent measurement points of each of the experimental groups
were normalized to the values at 24 hours after scratching, which
were set as 1. To ensure the involvement of PSA-NCAM in the
observed results, additional PSA cleavage experiments were
performed with addition of endoneuraminidase-N (EndoN;
ABC-abc0020; ABC Scientific, Los Angeles, CA, http://www.
abcscientific.com) at 1:5,000 dilution for 12 hours before intro-
ducing the scratch. To exclude the possibility that an increase
in cell number in the gap could be ascribed to increased cell pro-
liferation,wecounted the total numberof cells present in awell at
0, 24, 48, and 72 hours after scratching.
Transplantation of iPSC-Derived OPCs in Cuprizone
Mouse Model
In previous studies, we have shown that transplanted mouse
iPSC-derivedOPCs are able to remyelinate corpus callosum axons
that were demyelinated after mice were given a diet of 0.2% (wt/
wt) cuprizone [3]. These stereotactically injected OPCs demon-
strated a limitedmigration along the axonal bundles of the corpus
callosum. To examine the effect of increased expression of PSA-
NCAMs on themigration of implanted mouse iPSC-derived OPCs,
we stereotactically injected the modified OPCs in the corpus cal-
losum, as previously described. C57Bl/6mice were given a diet of
0.2% (wt/wt) cuprizone (Sigma-Aldrich), a copper chelator. This
diet leads to selective oligodendrocyte death, followed by demy-
elination of axons, mainly in the corpus callosum within 4–6
weeks [17, 18].During short-termexposure (,6weeks), dyingoli-
godendrocytes are replaced by OPCs located in the corpus cal-
losum and adjacent tissues. However, continuing the cuprizone
diet for a longer period results in depletion of the pool of endog-
enous OPCs in the corpus callosum and, finally, to its complete
demyelination [19]. At 9weeks after the start of the cuprizone di-
et, the mice were divided into 2 groups: 1 group (n = 6) received
a suspension of iPSC-derived OPCs transduced with an empty
vector, and 1 group (n = 6) was injected with a suspension of
STX-expressing iPSC-derived OPCs. Additionally, to identify the
implanted cells afterward in brain sections, theywere transduced
with lentivirus encoding for enhanced green fluorescent protein
(GFP) before OPC differentiation. On the day of transplantation,
the cells were harvested with Accutase (Sigma-Aldrich), counted,
and resuspended in PBS at a concentration of 25,000 cells per
microliter. Next, 4 ml of cell suspension was injected into the
corpus callosum of C57BL/6mice using the following stereotactic
coordinates (in reference to the Bregma point): +0.98 mm
(anteroposterior axis), 21.75 mm (lateromedial axis),22.25 mm
(vertical axis) [20, 21]. Next, suspensions of 100,000 cells in
4 ml PBS were slowly injected into the corpus callosum of
ketamine-anesthetized mice using a 10 ml Hamilton injection sy-
ringe (22s/2”/3) (80365; Hamilton Co., Reno, NV, http://www.
hamiltoncompany.com). Every injection was done within a stan-
dardizedwindow (i.e., 5-minute injection time and 2-minute depo-
sition rest) before needle retraction to prevent potential variation
in the effect of shearing forces. After implantation of the iPSC-
derivedOPCs, themicewere takenoff the cuprizone diet andgiven
the normal diet again to avoid degeneration of the implanted
OPCs by cuprizone. Mice with implantation of control and STX-
transfected iPSC-derived OPCs were perfusion fixated at 3 weeks.
In Vivo Migration Assay
The distances along which the GFP-labeled implanted cells mi-
grated in the demyelinated corpus callosum were measured
based on images of a brain section taken at the site of injection.
In brief, for every image, the center of the injection site was de-
termined, and the distances from that point to the GFP-labeled
cell bodies were measured. The results are presented as the
mean 6 SEM. For each condition/section, the migration of the
75 most distant cells was measured.
Immunocytochemistry
Immunocytochemistry was used to confirm the expression of the
transfected genes, to identify the reprogrammed and differenti-
ated cell types in culture, and to recognize and characterize iPSC-
derived OPCs after transplantation in the corpus callosum of
cuprizone fed mice. Cell cultures were fixed on coverslips for
15 minutes with 4% paraformaldehyde (Sigma-Aldrich) and then
washed 3 times with plain PBS. Nonspecific binding sites were
blocked for 1 hour in blocking solution (PBS plus 0.1% Triton, sup-
plemented with 5% normal goat serum [NGS] and 2% FCS). Pri-
mary antibodies (Table 2) were diluted in PBS plus 0.1% Triton
plus 1% FCS plus 1% NGS and applied overnight at 4°C. After in-
cubation, the cells were washed three times in PBS. Secondary
antibodies and Hoechst (1:1,000) were diluted in PBS plus 0.1%
Triton and applied for 1 hour at room temperature in the dark.
Afterwashing in PBS three times, the cellsweremounted on glass
slides using Mowiol (Sigma-Aldrich).
The mice that received stereotactic cell grafts were perfused
transcardially with 4% paraformaldehyde under isoflurane anes-
thesia. The brains were excised and sectioned on a cryostat for
detection and immunohistochemical analysis of the cell implants.
Implanted cells were identified by their expression of GFP. To
analyze the differentiation of the implanted cells, the primary
antibodies listed in Table 2 were used. Subsequently, various
fluorescent secondary antibodies were used to visualize the spe-
cific primary immunoreaction product in single anddouble immu-
nohistochemical stains.
RESULTS
iPSC-Derived NSCs and STX Transfection
Using lentiviral transduction of the E14 mouse embryonic fibro-
blasts with the Yamanaka pluripotency factors, we were able to
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generate several clones of iPSCs. These iPSCs were characterized
according to their expression of crucial endogenous pluripotent
transcription factors and pluripotency markers, at the mRNA
and protein level (supplemental online Fig. 2). We verified the
presence of all three germ layers after the formation of embryoid
bodies (data not shown).
We have chosen the intermediate NSC stage (Fig. 1A) in the
iPSC-OPC differentiation protocol for lentiviral transduction to in-
duce overexpression of STX and subsequent PSA-NCAM produc-
tion in the OPCs, because this method resulted in the highest
efficiency and expression level (data not shown). Selective differ-
entiation and survival of proliferating nestin-positive NSCs (Fig.
1A) was achieved by culturing enzymatically dissociated 8-day-
old iPSC-derived EBs in N2 medium in the presence of bFGF
and EGF.We transduced these iPSC-derived NSCswith a lentiviral
vector containing the gene encoding for STX and a separate con-
trol cell population with an empty vector using cell selection via
puromycin resistance. Most NSCs demonstrate a high level of
NCAM expression but only very low levels of PSA-NCAM (Fig.
1). After establishing successful STX gene transfection with
qRT-PCR (Fig. 1B), we were able to demonstrate high levels of
PSA-NCAM in STX-transfected NSCs (Fig. 1C, 1D) in contrast to
nontransfected or iPSC-derived NSCs transduced with an empty
vector (Fig. 1E, 1F). To verify the specificity of the NCAM polysia-
lylation by STX, we treated the transfected NSCs with EndoN for
24 hours and observed a complete reduction in the expression of
PSA-NCAM (Fig. 1G).
Differentiation of STX-Transfected iPSC-Derived NSCs
Into Functional OPCs
Using the previously published protocol to differentiate iPSCs
intoanoligodendrocytic cell lineage [3],wecontinued todifferen-
tiate the STX-transfected iPSC-derived NSCs into OPCs. A similar
pattern of OPC differentiation was observed for the STX-
transfected iPSC-derived NSCs as for the nontransfected control
NSCs (supplemental online Fig. 3). The resulting STX-transfected
iPSC-derived OPCs showed high expression of PSA-NCAM (Fig.
2A), in contrast to the minimal expression in the nontransfected
control NSCs after OPC differentiation (Fig. 2B). No differences in
morphology and differentiation were observed between the
groups. It is well known and functionally essential that during
the in vivo maturation of OPCs and the start of myelin formation,
oligodendrocytes downregulate STX activity and stop PSA-NCAM
formation to allow contacting axons. In our cultures, we observed
that nontransfected, as well as STX-transfected, OPCs, silenced
PSA-NCAM expression the moment they started to express
MBP (Fig. 2C, 2D), indicating that STX activity in the transfected
iPSC-derived OPCs was regulated similarly to control OPCs during
functional maturation.
To examine whether STX-overexpressing iPSC-derived
OPCswould show a similar in vitromyelination activity as empty
vector transduced iPSC-derived OPCs, we cocultured similar
numbers of them on coverslips containing a standardized num-
ber of rat DRG sensory neurons that had formed an extensive net-
work of long axons in 2 weeks of preculture (Fig. 2E, 2F). We
quantified the myelination efficiency for both OPC populations
and found no significant differences between them (Fig. 2G).
However, the STX-transfected OPCs seemed to be more dis-
persed over the DRG coculture, reflecting increased migration
activity compared with the controls, which stayed more
clustered.
PSA-NCAM and iPSC-Derived OPC Migration In Vitro
To examine the effect of STX-overexpression and the subsequent
presence of PSA-NCAM on the spontaneous migration activity
of iPSC-derived OPCs in vitro, we plated STX-transfected iPSC-
derived OPCs, parallel to the relevant control (nontransduced
or empty vector-transduced) iPSC-derivedOPCs in 12-well plates.
As an additional control, we treated STX-transfected iPSC-derived
OPCwith EndoN for 12 hours before plating. Endoneuraminidase
is an enzyme that cleaves PSA from the PSA-NCAM. In amodifica-
tion of the widely used wound healing in vitro assay, we induced
a gap of standardized dimensions by scratching through the mid-
dle of the plated cell cultures and examined the spontaneous
bridging of the different plated iPSC-derived OPC populations
after 3 days (Fig. 3A–3C). STX-transfected iPSC-derived OPCs
showed significantly increased migratory activity compared with
thecontrolOPCs, aneffect thatwasabolishedwhen thecellswere
treated with endoneuraminidase (Fig. 3D). To exclude the possi-
bility that the increase in cell number bridging the gapwas due to
an increase in proliferation, we counted all the cells at the start
and at different stages of the migration assay. No differences in
the proliferation rate were observed among the various iPS-
derived OPC populations (Fig. 3E)
PSA-NCAM and iPSC-Derived OPC Migration In Vivo
Feeding mice with a diet containing 0.2% cuprizone led to com-
plete demyelination of the corpus callosumafter 6weeks. Stereo-
tactic injection of iPSC-derived OPCs after 9 weeks of the
cuprizone diet at a standard location in the corpus callosum
was used to examine the migratory behavior and remyelination
along thenude axonbundles and the effect of STXoverexpression
on that. As has been demonstrated in previous studies [3],
injected mouse iPSC-derived OPCs survived and repopulated
the corpus callosum (Fig. 4). At 3 weeks after implantation,
most of the injected iPSC-derived OPCs had maturated into
Table 2. Antibodies used for immunohistochemistry




MBP AbD Serotec MCA409S





Oct4 Santa Cruz Biotechnology sc-5279
Nanog Abcam ab80892
Sox2 Cell Signaling #4900S




Abbreviations: GFP, green fluorescent protein; MBP, myelin-basic
protein; NCAM, neural cell adhesion molecule; NF, neurofilament;
PDGFRa, platelet-derived growth factor receptor-a; PSA-NCAM,
polysialic acid-neuronal cell adhesion molecule; SSEA, stage-specific
embryonic antigen.
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MBP-expressing oligodendrocytes, although immature OPCs
and some nestin-positive implanted cells could be detected
(supplemental online Fig. 4). A similar pattern of survival andmat-
uration was observed with the control and STX-transfected iPSC-
derived OPCs. However, considerable differences were seen in the
location and spread of the implanted iPSC-derived OPCs (Fig. 4B).
The iPSC-derivedOPCs expressing STX showed a significant increase
in migration along the axons (Fig. 4C) compared with the control
iPSC-derived OPCs (Fig. 4D) and had repopulated the corpus cal-
losum along its entire width at the unilateral side of the injection.
No difference in total cell survival between the control and STX-
transfected iPSC-derivedOPCs could beobserved (data not shown).
DISCUSSION
In this study, we demonstrated that forced overexpression of the
polysialic acid transferase STX in iPSC-derived OPCs significantly
increased their migration potential in vitro and in vivo compared
with control iPSC-derived OPCs, which are only able to form low
levels of PSA-NCAM [12].
Importantly, the STX-transfected iPS-derived OPCs retained
the capacity to downregulate PSA-NCAM formation at the mo-
ment they reached the myelin-forming stage, in line with previ-
ous findings of STX-transfected Schwann cells [8, 12, 15]. The
presence of PSA-NCAM has been shown to interfere with the
Figure 1. STX overexpression in iPSC-derived neural stem cells (NSCs). (A1–A3): Expression of NCAM and nestin in iPSC-derived NSCs merged
with Hoechst nuclear staining. (B): Quantitative polymerase chain reaction-normalized STX expression in control NSC groups (i.e., nontrans-
fected, EV-transfected, and STX-overexpressing NSCs). (C): Western blot showing NCAM and PSA-NCAM protein expression in control and
STX-transfected iPSC-derived NSCs. (D–F): PSA-NCAM immunostaining of control and STX-overexpressing iPSC-derived NSCs. (G1–G3): PSA-
NCAM immunostaining of STX-overexpressing NSCs after 24 hours of EndoN treatment. Scale bar = 100mm. Abbreviations: EndoN, endoneur-
aminidase-N; EV, empty vector; NCAM, neural cell adhesion molecule; Non, nontransfected; PSA-NCAM, polysialic acid-neural cell adhesion
molecule; STX, sialyltransferase X.
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proper maturation of OPCs and to inhibit the actual myelination
of axons [8, 9, 12, 13]. It has been proposed that axonal factors
can induce the downregulation of PSA-NCAM [8, 12]; how-
ever, apparently also in the absence of axons, maturating
iPSC-derived OPCs stop PSA-NCAM formation the moment
they produce one of the major myelin proteins, MBP. Whether
this is accomplished via epigenetic silencing of STX expression,
via an MBP-dependent feedback loop, at the translational
Figure 2. Differentiationof STX-overexpressing iPSC-derivedneural stemcells intooligodendrocytes. (A):Mostof thePDGFRa-positive (red) STX-
transfected iPSC-derived oligodendrocyte precursors (OPCs) express PSA-NCAM (green). (B): Nontransfected iPSC-derived OPCs show only very
low levels of PSA-NCAM. (C): During differentiation intomature oligodendrocytes, STX-transfected iPSC-derived OPCs start to expressMBP (red),
which is accompanied by complete downregulation of STX activity and loss of PSA-NCAM. Only the still undifferentiated STX-transfected iPSC-
derived OPCs between the MBP producing cells still express some PSA-NCAM. (D): Nontransfected iPSC-derived OPCs show a similar pattern
and no PSA-NCAM immunostaining could be detected after the start ofMBP expression. (E, F): Two-week-old coculture of rat dorsal root ganglion
(DRG)neurons (NF= red)with STX-overexpressing iPSC-derivedOPCs (E)or control (transfectedwithEV) iPSC-derivedOPCs (F). Bars =100mm. (G):
Graph indicatingmyelinationefficiency (seeMaterials andMethods section)ofSTX-overexpressing iPSC-derivedOPCs (STX)or control (transfected
with empty vector) iPSC-derived OPCs after 2 weeks of coculture with rat DRG neurons; no significant differences were found (Student’s t test).
Graph bar indicates mean6 SD. Abbreviations: EV, empty vector; MBP, myelin-basic protein; NF, neurofilament; Non, nontransfected; PDGFRa,
platelet-derived growth factor receptor-a; PSA-NCAM, polysialic acid-neuronal cell adhesion molecule; STX, sialyltransferase X.
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level, or via increased breakdown of PSA-NCAM remains to be
elucidated.
Our data imply that STX-transfected iPSC-derived OPCs have
the ability to repopulate and remyelinate awider area in the brain
after injection compared with unmodulated iPS-derived OPCs.
Obviously, the migratory activity of OPCs within the brain does
not depend only on the composition of the extracellular matrix.
Apart from physical barriers (e.g., the presence of an astrocytic
scar), the concentration and gradient of chemotactic signals play
a crucial role, as does the interactionwith activatedmicroglia and
the neuroinflammatory factors they release. In the cuprizone
mousemodel, oligodendrocytedegenerationandmyelindestruc-
tion result in a massive recruitment and activation of microglia in
the corpus callosum [17, 22]. Olah et al. [23] performed genome-
wide gene expression analysis ofmicroglia in the corpus callosum
during demyelination and remyelination in the mouse cuprizone
model. Remyelination in this model spontaneously occurs after
an episode of toxin-induced primary demyelination and normal
diet is restored. They provided evidence for the existence of
a microglia phenotype that supports remyelination already at
the onset of demyelination and persists throughout the remyeli-
nation process. During demyelination, these microglia appear to
be involved in the phagocytosis of myelin debris and apoptotic
cells; during remyelination, they express a cytokine and chemo-
kine repertoire, enabling them to activate and recruit endoge-
nous OPCs to the lesion site and deliver trophic support [23].
Although we did not include the final stage of actual remyelina-
tion in our experiments, the iPSC-derived OPCs that we injected
during this stage might have benefited from the presence of this
remyelination supporting microglia, after overcoming the activa-
tion ofmicroglia at the site of injection as a response to the tissue
damage induced by the stereotactic needle. Similar experiments
in mice depleted from microglia (e.g., by treatment with colony
stimulating factor 1 receptor inhibitors [24]), could help our un-
derstanding of the effect of microglia on the migration of
implanted OPCs.
As described for most intracerebral cell grafting studies in
experimental animals, most injected cells do not survive the
traumatic injection procedure and the transition to a hostile
environment. Only those cells that will finally succeed in specific
functional integration will survive over time. Most of the iPSC-
derived OPCs that survived in the corpus callosum migrated
and maturated toward a functional oligodendrocyte stage, al-
though immature iPSC-derived OPCs could still be detected. Oc-
casionally, nestin-positive cells could be observed between the
surviving implanted iPSC-derived OPCs (supplemental online
Fig. 4). Either these cells dedifferentiated into NSC-like cells, such
ashasbeendescribedbefore in vitro [25], or the cell implants con-
tained some PDGFRa-expressing NSCs. Additional purification
steps using more specific membrane markers for OPCs and/or
NSCs should be included to eliminate the contamination of these
NSCs. Recently, it was found that NSCs within intracerebral neu-
ronal grafts secrete chemoattractants for their neuronal progeny,
preventing extensive migration of these neurons into the host
brain [26]. It is as yet unclear whether the presence of NSCs in
our iPSC-derived OPC grafts similarly interfered with migration
of the OPCs. In none of our implantation experiments was tera-
toma formation by contaminating iPSCs observed.
Figure3. Comparisonof in vitromigration capacity of STX-overexpressing iPSC-derivedoligodendrocyte precursors (OPCs) and controls. (A–C):
Representative photographs of themigration assay of nontransfected (A), EV-transfected (B), and STX-transfectedOPCs (C) 48 hours after stan-
dard gap introduction showing increasedmigratory capacity of STX-overexpressingOPCs. The cells were pseudocolored red (bar = 100mm). (D):
Migration efficiency of differentOPC groups represented as gap area bridged by the iPSC-derivedOPCs at day 3. Data at day 1was normalized to
1 for each group. Two-way analysis of variance; pp, p, .01; n = 3. (E): Proliferation curves of the three different iPSC-derived OPC populations
during the migration assay, showing no significant differences. Abbreviations: EV, empty vector; Non, nontransfected; STX, sialyltransferase X;
STX+Endo, sialyltransferase X-transfected, endoneuraminidase-treated.
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CONCLUSION
Our findings indicate that the reach and efficacy of iPSC-derived
OPC transplantation in brain tissue near demyelinated areas can
be improved by stimulating the OPC migration potential via the
forced expression of PSA-NCAM.
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